Truist Financial’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-5,209
Closed -$432K – 2657
2023
Q2
$432K Sell
5,209
-2,250
-30% -$197K ﹤0.01% 2034
2023
Q1
$665K Sell
7,459
-4,794
-39% -$417K ﹤0.01% 1797
2022
Q4
$1.05M Buy
12,253
+4,198
+52% +$356K ﹤0.01% 1524
2022
Q3
$575K Sell
8,055
-2,232
-22% -$200K ﹤0.01% 1751
2022
Q2
$1M Buy
10,287
+213
+2% +$21.7K ﹤0.01% 1549
2022
Q1
$1.13M Buy
10,074
+2,246
+29% +$239K ﹤0.01% 1569
2021
Q4
$1.06M Buy
7,828
+3,269
+72% +$455K ﹤0.01% 1603
2021
Q3
$644K Buy
4,559
+264
+6% +$35.5K ﹤0.01% 1864
2021
Q2
$550K Buy
4,295
+1,104
+35% +$130K ﹤0.01% 1974
2021
Q1
$407K Sell
3,191
-1,140
-26% -$210K ﹤0.01% 2106
2020
Q4
$778K Sell
4,331
-13,930
-76% -$3.1M ﹤0.01% 1625
2020
Q3
$4.01M Buy
18,261
+15,175
+492% +$3.39M 0.01% 805
2020
Q2
$691K Buy
3,086
+764
+33% +$120K ﹤0.01% 1452
2020
Q1
$227K Buy
+2,322
New +$188K ﹤0.01% 2040

Other funds holding QDEL

Truist Financial's QDEL Position: Q3 2023 in Review

Truist Financial sold out of QuidelOrtho (QDEL) in Q3 2023, closing a stake of 5,209 shares — an estimated $432K sold.

Truist Financial first reported a position in QDEL in Q1 2020 and held it in 14 quarters. The position peaked at $4.01M in Q3 2020. 304 funds tracked by Wall St. Rank hold QDEL as of Q3 2023.

  • Truist Financial reported no remaining QuidelOrtho position as of Q3 2023 after selling out during the quarter.
  • Truist Financial sold 5,209 QuidelOrtho shares in Q3 2023, an estimated $432K.
  • Truist Financial first reported a position in QuidelOrtho in Q1 2020 and held it in 14 quarters.
  • Truist Financial's QuidelOrtho position peaked at $4.01M in Q3 2020.
  • 304 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2023.

Based on Truist Financial's 13F filing for Q3 2023, filed 14 Nov 2023.